<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-52fc-3a32-0153-2e772ecc10c0</uuid><title>Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF &lt;40%)</title><shortTitle>CMS145</shortTitle><emeasureid>145</emeasureid><guid>80744ae2-de81-4b16-a71d-69522eb865c5</guid><version>5.2.000</version><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="8a4d92b2-3946-cdae-0139-78e023917b91"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="83e9797c-adec-4446-8c35-3ffd5d981c66">PCPI(R) Foundation (PCPI[R])</steward><developers><developer id="d041e15c-a7a0-41b8-be5b-87340ecd14bc">American Medical Association (AMA)</developer><developer id="83e9797c-adec-4446-8c35-3ffd5d981c66">PCPI(R) Foundation (PCPI[R])</developer></developers><description>Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior MI or a current or prior LVEF &lt;40% who were prescribed beta-blocker therapy</description><copyright>Copyright 2015 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.</copyright><disclaimer>The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. 

The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. 

Commercial uses of the Measures require a license agreement between the user and the PCPI(R) Foundation (PCPI[R]), the American Medical Association (AMA), American College of Cardiology (ACC) or the American Heart Association (AHA).  Neither the AMA, nor ACC, nor AHA, nor the AMA-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI), now known as the PCPI, nor their members shall be responsible for any use of the Measures. 

AMA and PCPI encourage use of the Measures by other health care professionals, where appropriate.

THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, ACC, AHA, the PCPI and its members and former members of the AMA-PCPI disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. 

CPT(R) contained in the Measure specifications is copyright 2004-2015 American Medical Association. LOINC(R) is copyright 2004-2015 Regenstrief Institute, Inc. This material contains SNOMED CLINICAL TERMS (SNOMED CT[R]) copyright 2004-2015 International Health Terminology Standards Development Organisation (IHTSDO). ICD-10 is copyright 2015 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>Denominator 1: Patients with left ventricular systolic dysfunction (LVEF &lt;40%)
Denominator 2: Patients with a prior (resolved) (within the past 3 years) myocardial infarction</aggregation><rationale>Nonadherence to cardioprotective medications is prevalent among outpatients with coronary artery disease and can be associated with a broad range of adverse outcomes, including all-cause and cardiovascular mortality, cardiovascular hospitalizations, and the need for revascularization procedures.

A patient with a diagnosis of coronary artery disease seen within a 12 month period and LVEF &lt;40% should be taking either bisoprolol, carvedilol, or sustained release metoprolol succinate. While all beta-blockers appear to be of equal efficacy in patients with chronic stable coronary artery disease, these three medications have specifically shown to reduce mortality in patients with reduced LVEF.</rationale><recommendations>Beta-blocker therapy should be started and continued for 3 years in all patients with normal LV function after MI or ACS. (Class I, Level of Evidence: B) (ACCF/AHA/ACP/AATS/PCNA/SCAI/STS, 2012)

Beta-blocker therapy should be used in all patients with LV systolic dysfunction (EF &lt;= 40%) with heart failure or prior MI, unless contraindicated. (Use should be limited to carvedilol, metoprolol succinate, or bisoprolol, which have been shown to reduce risk of death.)  (Class I, Level of Evidence: A)  (ACCF/AHA/ACP/AATS/PCNA/SCAI/STS, 2012)</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB III, Kligfield PD, Krumholz HM, Kwong RYK, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164.</reference></references><definitions>Prescribed may include prescription given to the patient for beta-blocker therapy at one or more visits in the measurement period OR patient already taking beta-blocker therapy as documented in current medication list.

Prior Myocardial Infarction (MI) for denominator 2 is limited to those occurring within the past 3 years.</definitions><guidance>Beta-blocker therapy:
- For patients with prior MI, beta-blocker therapy includes any agent within the beta-blocker drug class. As of 2015, no recommendations or evidence are cited in current stable ischemic heart disease guidelines for preferential use of specific agents
- For patients with prior LVEF &lt;40%, beta-blocker therapy includes the following: bisoprolol, carvedilol, or sustained release metoprolol succinate

The requirement of "Count &gt;=2 of Encounter, Performed" is to establish that the eligible professional has an existing relationship with the patient.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period</initialPopDescription><denominatorDescription>Equals Initial Population who also have prior (within the past 3 years) MI or a current or prior LVEF &lt;40%</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients who were prescribed beta-blocker therapy</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)</denominatorExceptionsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex</supplementalData><qualityMeasureSet uuid="9027b53b-b397-49fa-bf60-3e876761ffc5">None</qualityMeasureSet>
<finalizedDate value="201603101503-0600"/>
</measureDetails><supplementalDataElements><elementRef id="8a4d92b2-3946-cdae-0139-78e023907b8c" name="ONC Administrative Sex"/><elementRef id="8a4d92b2-3946-cdae-0139-78e023907b8d" name="Race"/><elementRef id="8a4d92b2-3946-cdae-0139-78e023907b8e" name="Ethnicity"/><elementRef id="8a4d92b2-3946-cdae-0139-78e023917b8f" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Occurrence A of $CADEncounters145" instance="A" instanceOf="F56D3DB1-7A69-425B-A56B-332758D39B36" qdmVariable="true" uuid="0A6953A1-AA03-44FB-94D1-FE96AC75D321"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b95" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b96" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b98" type="qdm"/><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9a" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9c" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="ba78416f-e92d-4774-9d71-e44faf8a98d5" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="8a4d92b2-3946-cdae-0139-78e023917b91" type="qdm"/></relationalOp></subTree><subTree displayName="Age greater than or equal to 18 years at MP" qdmVariable="false" uuid="4CF5EB7B-051B-42C1-AFEC-468535A4DD85"><functionalOp displayName="Age&gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="8a4d92b2-3946-cdae-0139-78e023917b91" type="qdm"/></functionalOp></subTree><subTree displayName="CADEncounters145" qdmVariable="true" uuid="F56D3DB1-7A69-425B-A56B-332758D39B36"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b95" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b96" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b98" type="qdm"/><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9a" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9c" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="ba78416f-e92d-4774-9d71-e44faf8a98d5" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="8a4d92b2-3946-cdae-0139-78e023917b91" type="qdm"/></relationalOp></subTree><subTree displayName="Count greater than or equal to 2 of Enc Perf during MP" qdmVariable="false" uuid="BCB541F3-9730-452C-9CC1-5ABA83DB9F60"><functionalOp displayName="Count&gt;= 2 " operatorType="Greater Than or Equal To" quantity="2" type="COUNT"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b95" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b96" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b98" type="qdm"/><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9a" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9c" type="qdm"/><elementRef displayName="Patient Provider Interaction : Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9e" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="8a4d92b2-3946-cdae-0139-78e023917b91" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="Device Applied Cardiac Pacer SBE Occ A CADEncounters145" qdmVariable="false" uuid="25E841E9-EC0E-4860-9945-DBD94460D8F5"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Cardiac Pacer : Device, Applied" id="8a4d92b2-3946-cdae-0139-78e023927bb3" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="DX Atrioventricular Block overlaps Occ A of CADEncounters145" qdmVariable="false" uuid="98D5D988-9607-42F0-8D5E-79EF2453496F"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Atrioventricular Block : Diagnosis" id="22fb5109-00b8-465e-9707-5469a13a0c0a" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="DX CAD no MI overlaps Occ A of CADEncounters145 variable" qdmVariable="false" uuid="3857786E-3738-4FEB-892F-0BC278805B4C"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Coronary Artery Disease No MI : Diagnosis" id="a6479a0b-277b-4940-8dbe-9115c5b628ce" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="DX Cardiac Pacer in Situ SBE Occ A CADEncounters145" qdmVariable="false" uuid="EFFE0C55-CB8F-48E6-A44F-9F21F54241CE"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Cardiac Pacer in Situ : Diagnosis" id="6e45ae95-c557-400a-b773-0a74ef909e3b" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="DX MI EBS Occ A of CADEncounters145" qdmVariable="false" uuid="2E2CB97C-ACA6-431B-9BD7-13C57BF70487"><relationalOp displayName="&lt;= 3 years Ends Before Start Of" operatorType="Less Than or Equal To" quantity="3" type="EBS" unit="years"><elementRef displayName="Myocardial Infarction : Diagnosis" id="fd51ef22-9bfa-4836-8d7c-b58a572eff24" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Med Active BB Therapy for LSVD overlaps Occ A of CADEncounters145 variable" qdmVariable="false" uuid="D05C0232-22FB-4501-B4A1-007382D647B9"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Beta Blocker Therapy for LVSD : Medication, Active" id="8a4d92b2-3946-cdae-0139-78e023927bbd" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Med Active BB Therapy overlaps Occ A CADEncounters145" qdmVariable="false" uuid="4B617C81-B160-4A51-A143-08AAF2ABABB2"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Beta Blocker Therapy : Medication, Active" id="8a4d92b2-3946-cdae-0139-78e023927baf" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Med Order BB Therapy during Occ A CADEncounters145" qdmVariable="false" uuid="4579CF2A-0DF9-420C-BBD5-5E509370C47B"><relationalOp displayName="During" type="DURING"><elementRef displayName="Beta Blocker Therapy : Medication, Order" id="8a4d92b2-3946-cdae-0139-78e023917ba8" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Med Order BB Therapy for LSVD during Occ A of CADEncounters145 variable" qdmVariable="false" uuid="61D2432D-A252-449C-A228-6743C92AF8AB"><relationalOp displayName="During" type="DURING"><elementRef displayName="Beta Blocker Therapy for LVSD : Medication, Order" id="8a4d92b2-3946-cdae-0139-78e023927baa" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="MOST RECENT Occ B Phys Exam Perf HR SBSO Occ A" qdmVariable="false" uuid="0092FED0-36E5-4612-8CE4-4A54074ED5DD"><functionalOp displayName="Most Recent" type="MOST RECENT"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence B of Heart Rate : Physical Exam, Performed" id="89b570e7-9223-491c-91f0-a44a09e6eb1a" type="qdm"/><elementRef displayName="Occurrence A of Heart Rate : Physical Exam, Performed" id="b040460d-d080-4fa2-82c7-fba6b5eebf97" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="Occ A Phys Exam Perf HR result during Occ A of CADEncounters145 variable" qdmVariable="false" uuid="551170D7-A3A9-4CCA-B446-94063010458F"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Heart Rate : Physical Exam, Performed" id="b040460d-d080-4fa2-82c7-fba6b5eebf97" type="qdm"><attribute attrUUID="948dfc9f-b99b-4a89-9617-a3ef1dc0e697" comparisonValue="50" mode="Less Than" name="result" unit="bpm"/></elementRef><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Occ B Phys Exam Perf HR result during Occ A of CADEncounters145 variable" qdmVariable="false" uuid="62CA6EA7-06C6-4914-A33A-9693186C5CFE"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence B of Heart Rate : Physical Exam, Performed" id="89b570e7-9223-491c-91f0-a44a09e6eb1a" type="qdm"><attribute attrUUID="664f887f-9341-47c4-a372-1975f02a1273" comparisonValue="50" mode="Less Than" name="result" unit="bpm"/></elementRef><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Proc Perf Cardiac Surgery SBE Occ A of CADEncounters145 variable" qdmVariable="false" uuid="7D5AD0CD-C6A2-463C-908A-54ACCE7D2089"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Cardiac Surgery : Procedure, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b93" type="qdm"/><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Union DX Med Intol Med Allergy overlaps Occ A of CADEncounters145" qdmVariable="false" uuid="4AA20DF5-E35E-467F-8EB7-CDFBA4E432A6"><relationalOp displayName="Overlaps" type="Overlap"><setOp displayName="Union" type="union"><elementRef displayName="Arrhythmia : Diagnosis" id="8f869e20-1f1e-402e-a516-7eb98562d079" type="qdm"/><elementRef displayName="Hypotension : Diagnosis" id="fb4c6a5b-a609-4355-ad15-220360203d86" type="qdm"/><elementRef displayName="Asthma : Diagnosis" id="4463d46d-0303-4ff7-9da9-7cace9732a63" type="qdm"/><elementRef displayName="Allergy to Beta Blocker Therapy : Diagnosis" id="6ded81a5-ac70-47c1-a534-9aee60c85bdb" type="qdm"/><elementRef displayName="Beta Blocker Therapy : Medication, Intolerance" id="8a4d92b2-3946-cdae-0139-78e023927bb7" type="qdm"/><elementRef displayName="Intolerance to Beta Blocker Therapy : Diagnosis" id="97bbd204-8daf-49c0-b4e7-cf8c494b0f4b" type="qdm"/><elementRef displayName="Bradycardia : Diagnosis" id="927cab58-6a26-4739-b482-760ee5f319a6" type="qdm"/><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Allergy" id="40280381-3d61-56a7-013e-658031d33c36" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Union EjectionFraction result DX LVSD mod or severe SBE OccA CADEncounters" qdmVariable="false" uuid="ED5E66F8-7B1D-4EDC-9084-E2934B8209E4"><relationalOp displayName="Starts Before End Of" type="SBE"><setOp displayName="Union" type="union"><elementRef displayName="Ejection Fraction : Diagnostic Study, Performed" id="8a4d92b2-3946-cdae-0139-78e023917ba0" type="qdm"><attribute attrUUID="867af376-ece6-474f-b6c6-4d8606b5943d" comparisonValue="40" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Moderate or Severe LVSD : Diagnosis" id="26b99bd6-c6f3-4923-b4cb-ac939c812c9a" type="qdm"/><elementRef displayName="Left Ventricular Systolic Dysfunction : Diagnosis" id="89ac25af-f8b0-4932-b62b-06d6e336d282" type="qdm"><attribute attrUUID="261e0402-88f1-4129-87c5-cb498582b760" mode="Value Set" name="severity" qdmUUID="8a4d92b2-3946-cdae-0139-78e023917ba5"/></elementRef></setOp><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree><subTree displayName="Union Med Order Not Done for BB Therapy Ingred starts during Occ A Variable" qdmVariable="false" uuid="40623A43-6F34-4278-A054-1269DFD4CDF0"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="Union" type="union"><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="33607d22-e0c2-4774-9c36-ecc88e3c60c5" type="qdm"><attribute attrUUID="9d0f6633-af46-4317-a67e-4e2cc7350f90" mode="Value Set" name="negation rationale" qdmUUID="8a4d92b2-3946-cdae-0139-78e023927bac"/></elementRef><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="33607d22-e0c2-4774-9c36-ecc88e3c60c5" type="qdm"><attribute attrUUID="166f6149-9b6b-4054-be35-c194acf894bb" mode="Value Set" name="negation rationale" qdmUUID="8a4d92b2-3946-cdae-0139-78e023927bad"/></elementRef><elementRef displayName="Beta Blocker Therapy Ingredient : Medication, Order" id="33607d22-e0c2-4774-9c36-ecc88e3c60c5" type="qdm"><attribute attrUUID="bc24ec61-1355-4ee6-816b-6ad28bf02277" mode="Value Set" name="negation rationale" qdmUUID="8a4d92b2-3946-cdae-0139-78e023927bae"/></elementRef></setOp><subTreeRef displayName="Occurrence A of CADEncounters145" id="0A6953A1-AA03-44FB-94D1-FE96AC75D321" type="subTree"/></relationalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="27982FD6-7C42-44E7-A871-0BB7F858A6D5"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 18 years at MP" id="4CF5EB7B-051B-42C1-AFEC-468535A4DD85" type="subTree"/><subTreeRef displayName="Count greater than or equal to 2 of Enc Perf during MP" id="BCB541F3-9730-452C-9CC1-5ABA83DB9F60" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="DX CAD no MI overlaps Occ A of CADEncounters145 variable" id="3857786E-3738-4FEB-892F-0BC278805B4C" type="subTree"/><subTreeRef displayName="Proc Perf Cardiac Surgery SBE Occ A of CADEncounters145 variable" id="7D5AD0CD-C6A2-463C-908A-54ACCE7D2089" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="2294F966-EECD-4C61-8D94-D5E4B09BD9BB"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Union EjectionFraction result DX LVSD mod or severe SBE OccA CADEncounters" id="ED5E66F8-7B1D-4EDC-9084-E2934B8209E4" type="subTree"/></logicalOp></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="487E15AB-CDE2-4955-9B93-1A2CDAE6B1F2"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="MOST RECENT Occ B Phys Exam Perf HR SBSO Occ A" id="0092FED0-36E5-4612-8CE4-4A54074ED5DD" type="subTree"/><subTreeRef displayName="Occ A Phys Exam Perf HR result during Occ A of CADEncounters145 variable" id="551170D7-A3A9-4CCA-B446-94063010458F" type="subTree"/><subTreeRef displayName="Occ B Phys Exam Perf HR result during Occ A of CADEncounters145 variable" id="62CA6EA7-06C6-4914-A33A-9693186C5CFE" type="subTree"/></logicalOp><subTreeRef displayName="Union Med Order Not Done for BB Therapy Ingred starts during Occ A Variable" id="40623A43-6F34-4278-A054-1269DFD4CDF0" type="subTree"/><subTreeRef displayName="Union DX Med Intol Med Allergy overlaps Occ A of CADEncounters145" id="4AA20DF5-E35E-467F-8EB7-CDFBA4E432A6" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="DX Atrioventricular Block overlaps Occ A of CADEncounters145" id="98D5D988-9607-42F0-8D5E-79EF2453496F" type="subTree"/><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="DX Cardiac Pacer in Situ SBE Occ A CADEncounters145" id="EFFE0C55-CB8F-48E6-A44F-9F21F54241CE" type="subTree"/><subTreeRef displayName="Device Applied Cardiac Pacer SBE Occ A CADEncounters145" id="25E841E9-EC0E-4860-9945-DBD94460D8F5" type="subTree"/></logicalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="02A4DDAC-D615-457A-9304-F1E382D3811C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Med Order BB Therapy for LSVD during Occ A of CADEncounters145 variable" id="61D2432D-A252-449C-A228-6743C92AF8AB" type="subTree"/><subTreeRef displayName="Med Active BB Therapy for LSVD overlaps Occ A of CADEncounters145 variable" id="D05C0232-22FB-4501-B4A1-007382D647B9" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="e497e337-9671-4805-94e9-1c7113bf187b"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="fad68323-0812-4509-8283-5913d09d323c"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="3b286de0-00bb-41de-83fd-0ed51f22f913"/></group><group sequence="2"><clause displayName="Initial Population 1" type="initialPopulation" uuid="2EE8137A-4627-471C-8837-85BDBF665017"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 18 years at MP" id="4CF5EB7B-051B-42C1-AFEC-468535A4DD85" type="subTree"/><subTreeRef displayName="Count greater than or equal to 2 of Enc Perf during MP" id="BCB541F3-9730-452C-9CC1-5ABA83DB9F60" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="DX CAD no MI overlaps Occ A of CADEncounters145 variable" id="3857786E-3738-4FEB-892F-0BC278805B4C" type="subTree"/><subTreeRef displayName="Proc Perf Cardiac Surgery SBE Occ A of CADEncounters145 variable" id="7D5AD0CD-C6A2-463C-908A-54ACCE7D2089" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator 2" type="denominator" uuid="CC31BC83-F06C-4381-8A4F-1EEBE9ECF7BC"><logicalOp displayName="AND" type="and"><subTreeRef displayName="DX MI EBS Occ A of CADEncounters145" id="2E2CB97C-ACA6-431B-9BD7-13C57BF70487" type="subTree"/></logicalOp></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="F79E2A13-6F9E-4B84-99E0-4603E99C83C3"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="MOST RECENT Occ B Phys Exam Perf HR SBSO Occ A" id="0092FED0-36E5-4612-8CE4-4A54074ED5DD" type="subTree"/><subTreeRef displayName="Occ A Phys Exam Perf HR result during Occ A of CADEncounters145 variable" id="551170D7-A3A9-4CCA-B446-94063010458F" type="subTree"/><subTreeRef displayName="Occ B Phys Exam Perf HR result during Occ A of CADEncounters145 variable" id="62CA6EA7-06C6-4914-A33A-9693186C5CFE" type="subTree"/></logicalOp><subTreeRef displayName="Union Med Order Not Done for BB Therapy Ingred starts during Occ A Variable" id="40623A43-6F34-4278-A054-1269DFD4CDF0" type="subTree"/><subTreeRef displayName="Union DX Med Intol Med Allergy overlaps Occ A of CADEncounters145" id="4AA20DF5-E35E-467F-8EB7-CDFBA4E432A6" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="DX Atrioventricular Block overlaps Occ A of CADEncounters145" id="98D5D988-9607-42F0-8D5E-79EF2453496F" type="subTree"/><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="DX Cardiac Pacer in Situ SBE Occ A CADEncounters145" id="EFFE0C55-CB8F-48E6-A44F-9F21F54241CE" type="subTree"/><subTreeRef displayName="Device Applied Cardiac Pacer SBE Occ A CADEncounters145" id="25E841E9-EC0E-4860-9945-DBD94460D8F5" type="subTree"/></logicalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 2" type="numerator" uuid="5C03C433-8F8A-4204-B536-D7381835CE8C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Med Order BB Therapy during Occ A CADEncounters145" id="4579CF2A-0DF9-420C-BBD5-5E509370C47B" type="subTree"/><subTreeRef displayName="Med Active BB Therapy overlaps Occ A CADEncounters145" id="4B617C81-B160-4A51-A143-08AAF2ABABB2" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="1804358a-4620-44e2-8fb9-526eecdc2fd1"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="cec3a188-ef61-41da-a88d-84a6bea90aa9"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="36451781-fbb2-4703-b1d1-7dabd8ecc0d4"/></group></measureGrouping><elementLookUp><qdm datatype="Diagnosis" id="6ded81a5-ac70-47c1-a534-9aee60c85bdb" name="Allergy to Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1177" suppDataElement="false" taxonomy="Grouping" uuid="6ded81a5-ac70-47c1-a534-9aee60c85bdb" version="1.0"/><qdm datatype="Diagnosis" id="8f869e20-1f1e-402e-a516-7eb98562d079" name="Arrhythmia" oid="2.16.840.1.113883.3.526.3.366" suppDataElement="false" taxonomy="Grouping" uuid="8f869e20-1f1e-402e-a516-7eb98562d079" version="1.0"/><qdm datatype="Diagnosis" id="4463d46d-0303-4ff7-9da9-7cace9732a63" name="Asthma" oid="2.16.840.1.113883.3.526.3.362" suppDataElement="false" taxonomy="Grouping" uuid="4463d46d-0303-4ff7-9da9-7cace9732a63" version="1.0"/><qdm datatype="Diagnosis" id="22fb5109-00b8-465e-9707-5469a13a0c0a" name="Atrioventricular Block" oid="2.16.840.1.113883.3.526.3.367" suppDataElement="false" taxonomy="Grouping" uuid="22fb5109-00b8-465e-9707-5469a13a0c0a" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="8a4d92b2-3946-cdae-0139-78e023917ba8" name="Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1174" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917ba8" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Active" id="8a4d92b2-3946-cdae-0139-78e023927baf" name="Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1174" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927baf" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Intolerance" id="8a4d92b2-3946-cdae-0139-78e023927bb7" name="Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1174" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bb7" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="8a4d92b2-3946-cdae-0139-78e023927baa" name="Beta Blocker Therapy for LVSD" oid="2.16.840.1.113883.3.526.3.1184" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927baa" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Active" id="8a4d92b2-3946-cdae-0139-78e023927bbd" name="Beta Blocker Therapy for LVSD" oid="2.16.840.1.113883.3.526.3.1184" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bbd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Allergy" id="40280381-3d61-56a7-013e-658031d33c36" name="Beta Blocker Therapy Ingredient" oid="2.16.840.1.113883.3.526.3.1493" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-658031d33c36" version="1"/><qdm datatype="Medication, Order" id="33607d22-e0c2-4774-9c36-ecc88e3c60c5" name="Beta Blocker Therapy Ingredient" oid="2.16.840.1.113883.3.526.3.1493" suppDataElement="false" taxonomy="Grouping" uuid="33607d22-e0c2-4774-9c36-ecc88e3c60c5" version="1.0"/><qdm datatype="Patient Characteristic Birthdate" id="75571c85-e5d3-43bb-b8d9-66de0a2163df" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="75571c85-e5d3-43bb-b8d9-66de0a2163df" version="1.0"/><qdm datatype="Diagnosis" id="927cab58-6a26-4739-b482-760ee5f319a6" name="Bradycardia" oid="2.16.840.1.113883.3.526.3.412" suppDataElement="false" taxonomy="Grouping" uuid="927cab58-6a26-4739-b482-760ee5f319a6" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Device, Applied" id="8a4d92b2-3946-cdae-0139-78e023927bb3" name="Cardiac Pacer" oid="2.16.840.1.113883.3.526.3.1193" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bb3" version="1"/><qdm datatype="Diagnosis" id="6e45ae95-c557-400a-b773-0a74ef909e3b" name="Cardiac Pacer in Situ" oid="2.16.840.1.113883.3.526.3.368" suppDataElement="false" taxonomy="Grouping" uuid="6e45ae95-c557-400a-b773-0a74ef909e3b" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Procedure, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b93" name="Cardiac Surgery" oid="2.16.840.1.113883.3.526.3.371" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b93" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9a" name="Care Services in Long-Term Residential Facility" oid="2.16.840.1.113883.3.464.1003.101.12.1014" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b9a" version="1"/><qdm datatype="Diagnosis" id="a6479a0b-277b-4940-8dbe-9115c5b628ce" name="Coronary Artery Disease No MI" oid="2.16.840.1.113883.3.526.3.369" suppDataElement="false" taxonomy="Grouping" uuid="a6479a0b-277b-4940-8dbe-9115c5b628ce" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnostic Study, Performed" id="8a4d92b2-3946-cdae-0139-78e023917ba0" name="Ejection Fraction" oid="2.16.840.1.113883.3.526.3.1134" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917ba0" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="8a4d92b2-3946-cdae-0139-78e023907b8e" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="8a4d92b2-3946-cdae-0139-78e023907b8e" version="1"/><qdm datatype="Patient Characteristic Expired" id="a09fa0dc-89db-45c2-ab89-77e24f519846" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="a09fa0dc-89db-45c2-ab89-77e24f519846" version="1.0"/><qdm datatype="Encounter, Performed" id="ba78416f-e92d-4774-9d71-e44faf8a98d5" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="ba78416f-e92d-4774-9d71-e44faf8a98d5" version="1.0"/><qdm datatype="Physical Exam, Performed" id="b040460d-d080-4fa2-82c7-fba6b5eebf97" instance="Occurrence A" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="b040460d-d080-4fa2-82c7-fba6b5eebf97" version="1.0"/><qdm datatype="Physical Exam, Performed" id="89b570e7-9223-491c-91f0-a44a09e6eb1a" instance="Occurrence B" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="89b570e7-9223-491c-91f0-a44a09e6eb1a" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9c" name="Home Healthcare Services" oid="2.16.840.1.113883.3.464.1003.101.12.1016" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b9c" version="1"/><qdm datatype="Diagnosis" id="fb4c6a5b-a609-4355-ad15-220360203d86" name="Hypotension" oid="2.16.840.1.113883.3.526.3.370" suppDataElement="false" taxonomy="Grouping" uuid="fb4c6a5b-a609-4355-ad15-220360203d86" version="1.0"/><qdm datatype="Diagnosis" id="97bbd204-8daf-49c0-b4e7-cf8c494b0f4b" name="Intolerance to Beta Blocker Therapy" oid="2.16.840.1.113883.3.526.3.1178" suppDataElement="false" taxonomy="Grouping" uuid="97bbd204-8daf-49c0-b4e7-cf8c494b0f4b" version="1.0"/><qdm datatype="Diagnosis" id="89ac25af-f8b0-4932-b62b-06d6e336d282" name="Left Ventricular Systolic Dysfunction" oid="2.16.840.1.113883.3.526.3.1091" suppDataElement="false" taxonomy="Grouping" uuid="89ac25af-f8b0-4932-b62b-06d6e336d282" version="1.0"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="8a4d92b2-3946-cdae-0139-78e023917b91" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="8a4d92b2-3946-cdae-0139-78e023917b91" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="8a4d92b2-3946-cdae-0139-78e023927bac" name="Medical Reason" oid="2.16.840.1.113883.3.526.3.1007" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bac" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="8a4d92b2-3946-cdae-0139-78e023917ba5" name="Moderate or Severe" oid="2.16.840.1.113883.3.526.3.1092" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917ba5" version="1"/><qdm datatype="Diagnosis" id="26b99bd6-c6f3-4923-b4cb-ac939c812c9a" name="Moderate or Severe LVSD" oid="2.16.840.1.113883.3.526.3.1090" suppDataElement="false" taxonomy="Grouping" uuid="26b99bd6-c6f3-4923-b4cb-ac939c812c9a" version="1.0"/><qdm datatype="Diagnosis" id="fd51ef22-9bfa-4836-8d7c-b58a572eff24" name="Myocardial Infarction" oid="2.16.840.1.113883.3.526.3.403" suppDataElement="false" taxonomy="Grouping" uuid="fd51ef22-9bfa-4836-8d7c-b58a572eff24" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b98" name="Nursing Facility Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1012" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b98" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b95" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b95" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="8a4d92b2-3946-cdae-0139-78e023907b8c" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="8a4d92b2-3946-cdae-0139-78e023907b8c" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b96" name="Outpatient Consultation" oid="2.16.840.1.113883.3.464.1003.101.12.1008" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b96" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Encounter, Performed" id="8a4d92b2-3946-cdae-0139-78e023917b9e" name="Patient Provider Interaction" oid="2.16.840.1.113883.3.526.3.1012" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023917b9e" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="8a4d92b2-3946-cdae-0139-78e023927bad" name="Patient Reason" oid="2.16.840.1.113883.3.526.3.1008" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bad" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="8a4d92b2-3946-cdae-0139-78e023917b8f" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="8a4d92b2-3946-cdae-0139-78e023917b8f" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="8a4d92b2-3946-cdae-0139-78e023907b8d" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="8a4d92b2-3946-cdae-0139-78e023907b8d" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="8a4d92b2-3946-cdae-0139-78e023927bae" name="System Reason" oid="2.16.840.1.113883.3.526.3.1009" suppDataElement="false" taxonomy="Grouping" uuid="8a4d92b2-3946-cdae-0139-78e023927bae" version="1"/><qdm datatype="Physical Exam, Performed" id="43d74f4c-2efd-45aa-aaa8-44d0a6c46b8f" name="Heart Rate" oid="2.16.840.1.113883.3.526.3.1176" suppDataElement="false" taxonomy="Grouping" uuid="43d74f4c-2efd-45aa-aaa8-44d0a6c46b8f" version="1.0"/></elementLookUp></measure>